Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent J Riley

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuro-Oncology|September 18, 2010
Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumorsShinji Kawabata, Weilian Yang, Rolf F Barth, et al.
Radiation Research|June 28, 2008
Functional and histological changes in rat lung after boron neutron capture therapyJingli Liu Kiger, W S Kiger, Kent J Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2008
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Gong Wu, et al.
Journal of Neuro-Oncology|July 10, 2009
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumorsWeilian Yang, Rolf F Barth, Gong Wu, et al.
Radiation Oncology (London, England)|August 30, 2012
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancerRolf F Barth, M Graca H Vicente, Otto K Harling, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agentRolf F Barth, Gong Wu, Weilian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodiesWeilian Yang, Gong Wu, Rolf F Barth, et al.
Journal of Neuro-Oncology|May 17, 2003
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial diseasePaul M Busse, Otto K Harling, Matthew R Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4Weilian Yang, Rolf F Barth, Gong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximabGong Wu, Weilian Yang, Rolf F Barth, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuro-Oncology|September 18, 2010
Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumorsShinji Kawabata, Weilian Yang, Rolf F Barth, et al.
Radiation Research|June 28, 2008
Functional and histological changes in rat lung after boron neutron capture therapyJingli Liu Kiger, W S Kiger, Kent J Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2008
Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Gong Wu, et al.
Journal of Neuro-Oncology|July 10, 2009
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumorsWeilian Yang, Rolf F Barth, Gong Wu, et al.
Radiation Oncology (London, England)|August 30, 2012
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancerRolf F Barth, M Graca H Vicente, Otto K Harling, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agentRolf F Barth, Gong Wu, Weilian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodiesWeilian Yang, Gong Wu, Rolf F Barth, et al.
Journal of Neuro-Oncology|May 17, 2003
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial diseasePaul M Busse, Otto K Harling, Matthew R Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4Weilian Yang, Rolf F Barth, Gong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximabGong Wu, Weilian Yang, Rolf F Barth, et al.
Pageof 2